101 Medicine information systems
Health and Care Act 2022 (2022 c 31) | Legislation

101  Medicine information systems

(1)     The Medicines and Medical Devices Act 2021 is amended in accordance with subsections (2) to (9).

(2)     In Part 2, for the heading of Chapter 1 substitute “Regulations: general”.

(3)     After that Chapter insert—

“Chapter 1A
Regulations: Information Systems

7A Information systems

(1)     The appropriate authority may by regulations make provision about the establishment and operation by the Health and Social Care Information Centre (“the Information Centre”) of one or more information systems for purposes relating to—

(a)     the safety of human medicines, including the safety of clinical decisions relating to human medicines;

(b)     the quality and efficacy of human medicines.

(2)     The regulations may (among other things) make provision—

(a)     about the information in relation to human medicines which may or must be entered or retained in an information system established under subsection (1);

(b)     requiring information to be provided to the Information Centre for the purposes of its functions under the regulations;

(c)     about the use or disclosure of information contained in an information system established under subsection (1);

(d)     requiring the Information Centre to have regard to specified matters in exercising its functions under the regulations.

(3)     The provision mentioned

Powered by Lexis+®
 

Popular documents

LEXISNEXIS

Reversionary lease by reference

 LR1. Date of the lease[date]LR2. Title Number(s)LR2.1 Landlord's title number(s)[title numbers out of which this Lease is granted. Leave blank if not registered]LR2.2 Other title numbers[existing title number(s) against which entries of matters referred to in LR9, LR10, LR11 and LR13 are to be

LEXISNEXIS

Grounds of appeal—introducing new evidence

Grounds of appeal—introducing new evidenceCoronavirus (COVID-19): The guidance detailing normal practice set out in this Practice Note may be affected by measures concerning process and procedure in the civil courts that have been introduced as a result of the coronavirus (COVID-19) pandemic. The

LEXISNEXIS

Section 2(1) of the Misrepresentation Act 1967 allows a claimant to claim damages for non-fraudulent

Section 2(1) of the Misrepresentation Act 1967 allows a claimant to claim damages for non-fraudulent misrepresentation, unless the representor can prove they had reasonable grounds for believing the statement to be true. If the representor had reasonable grounds for believing the statement to be

LEXISNEXIS

Defects liability period and rectification of defects

Defects liability period and rectification of defectsIt is common in construction projects for defects to manifest or appear in the works. Most construction contracts require the contractor to return to site to rectify (also known as ‘make good’) defects which arise or are discovered during a